Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer by Rachinger Andrea, Bartnik Ewa, Kupryjanczyk Jolanta, Bragoszewski Piotr, Ostrowski Jerzy

Get full text

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study by Markowska Janina, Timorek Agnieszka, Madry Radoslaw, Ziolkowska-Seta Izabela, Kraszewska Ewa, Kupryjanczyk Jolanta, Stelmachow Jerzy, Bidzinski Mariusz

Get full text

HAX-1 overexpression, splicing and cellular localization in tumors by Kupryjanczyk Jolanta, Rowinski Sebastian, Ptaszynski Konrad, Ciosek Karolina, Rembiszewska Alina, Trebinska Alicja, Siedlecki Janusz A, Grzybowska Ewa A

Get full text

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients by Felisiak-Golabek Anna, Rembiszewska Alina, Rzepecka Iwona K, Szafron Lukasz, Madry Radoslaw, Murawska Magdalena, Napiorkowski Tomasz, Sobiczewski Piotr, Osuch Beata, Kupryjanczyk Jolanta

Get full text